Revvity Inc (RVTY)
115.99
-3.75
(-3.13%)
USD |
NYSE |
Nov 14, 16:00
116.06
+0.07
(+0.06%)
After-Hours: 20:00
Revvity Research and Development Expense (Quarterly): 49.14M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 49.14M |
| June 30, 2024 | 48.13M |
| March 31, 2024 | 50.36M |
| December 31, 2023 | 49.60M |
| September 30, 2023 | 53.04M |
| June 30, 2023 | 57.25M |
| March 31, 2023 | 56.69M |
| December 31, 2022 | 54.54M |
| September 30, 2022 | 53.52M |
| June 30, 2022 | 56.04M |
| March 31, 2022 | 57.52M |
| December 31, 2021 | 60.58M |
| September 30, 2021 | 49.42M |
| June 30, 2021 | 65.82M |
| March 31, 2021 | 60.22M |
| December 31, 2020 | -2.125M |
| September 30, 2020 | 50.13M |
| June 30, 2020 | 49.52M |
| March 31, 2020 | 48.91M |
| December 31, 2019 | 47.64M |
| September 30, 2019 | 45.38M |
| June 30, 2019 | 48.34M |
| March 31, 2019 | 47.98M |
| December 31, 2018 | 51.97M |
| September 30, 2018 | 48.85M |
| Date | Value |
|---|---|
| June 30, 2018 | 47.20M |
| March 31, 2018 | 45.98M |
| December 31, 2017 | 37.73M |
| September 30, 2017 | 34.88M |
| June 30, 2017 | 33.56M |
| March 31, 2017 | 33.29M |
| December 31, 2016 | 32.83M |
| September 30, 2016 | 29.51M |
| June 30, 2016 | 31.87M |
| March 31, 2016 | 29.97M |
| December 31, 2015 | 16.64M |
| September 30, 2015 | 31.10M |
| June 30, 2015 | 32.68M |
| March 31, 2015 | 32.12M |
| December 31, 2014 | 17.88M |
| September 30, 2014 | 30.44M |
| June 30, 2014 | 30.35M |
| March 31, 2014 | 29.38M |
| December 31, 2013 | 32.59M |
| September 30, 2013 | 31.41M |
| June 30, 2013 | 34.40M |
| March 31, 2013 | 34.18M |
| December 31, 2012 | 32.73M |
| September 30, 2012 | 32.41M |
| June 30, 2012 | 34.07M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
-2.125M
Minimum
Dec 2020
65.82M
Maximum
Jun 2021
50.80M
Average
51.70M
Median
Research and Development Expense (Quarterly) Benchmarks
| Bionano Genomics Inc | 6.831M |
| Avantor Inc | -- |
| Bruker Corp | 98.10M |
| Azenta Inc | 7.913M |
| Harvard Bioscience Inc | 2.567M |